ImageneBio (IMA) Cash from Financing Activities (2020 - 2025)

ImageneBio (IMA) posted Cash from Financing Activities of $27000.0 for Q1 2025, down 55.0% sequentially from $60000.0 in Q4 2023.

ImageneBio (IMA) Cash from Financing Activities (2020 - 2025) Analysis & Trends

ImageneBio has reported Cash from Financing Activities for 5 years, with the latest figure at $27000.0 in Q1 2025.

Quarterly Cash from Financing Activities changed N/A year-over-year to $27000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $39.0 million (changed N/A YoY) and the FY2023 annual result came in at $76.0 million, up 6838.81% from the prior year.
Cash from Financing Activities fell to $27000.0 in Q1 2025 per IMA's latest filing, from $60000.0 in the prior quarter.
Over five years, Cash from Financing Activities peaked at $132.5 million in Q1 2021 and troughed at -$1.1 million in Q2 2021.
A 4-year average of $15.6 million and a median of $69000.0 in 2021 frame the typical range for Cash from Financing Activities.
The widest YoY moves for Cash from Financing Activities: up 630985.71% in 2021, down 99.8% in 2021.
Over 4 years, Cash from Financing Activities stood at $236000.0 in 2021, then tumbled by 99.58% to $1000.0 in 2022, then soared by 5900.0% to $60000.0 in 2023, then sank by 55.0% to $27000.0 in 2025.
According to Business Quant data, Cash from Financing Activities over the past three periods registered $27000.0, $60000.0, and $38.9 million for Q1 2025, Q4 2023, and Q3 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Financing Activities (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-426.70 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-1.22 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	14.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-6.05 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	36.24 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-16.65 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	27.18 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-273.15 Mn
10	ImageneBio	47.79 Mn	-87.56 Mn	-	-

Download Data